The influence of antioxidant supplementation on adverse effects and tumor interaction during radiotherapy: a systematic review
The influence of antioxidant supplementation on adverse effects and tumor interaction during radiotherapy: a systematic review
Limbrunner et al., 2025 | Clin Exp Med | Systematic Review
Citation
Limbrunner Julius, Doerfler Jennifer, ... Huebner Jutta. The influence of antioxidant supplementation on adverse effects and tumor interaction during radiotherapy: a systematic review. Clin Exp Med. 2025-Jul-22;25(1):258. doi:10.1007/s10238-025-01804-x
Abstract
Radiotherapy is essential in cancer treatment, using ionizing radiation to generate free radicals in the irradiated tissue or to directly damage DNA. Despite comprehensive safety measures, healthy tissue is also irradiated, causing side effects like oral mucositis and dermatitis. Antioxidants, which are known for scavenging free radicals, may reduce these adverse effects, but their impact on radiotherapy efficacy remains unclear. The aim of this systematic review was to evaluate the influence of antioxidant supplementation on radiation-induced side effects, tumor outcome and quality of life. In April 2024, a systematic research was conducted searching five databases (Medline, CINAHL, EMBASE, Cochrane CENTRAL, PsycINFO) to find studies looking at the effect of antioxidant supplementation during radiotherapy on radiation-induced side effects and parameters of tumor outcome or survival. Antioxidants can mitigate radiation-induced side effects, with vitamins C and E showing positive effects on oral mucositis, xerostomia and cardiac function. Curcumin and EGCG improved symptoms such as mucositis, dermatitis and esophagitis, while glutathione-enhanced treatment compliance but did not provide significant protection against side effects. However, multiple studies indicate that the concurrent use of antioxidants during cancer treatment may impair tumor control, increase recurrence rates and reduce survival outcomes. Antioxidants may reduce radiation-induced side effects but could compromise treatment efficacy. Due to inconsistent evidence and potential risks, clinical recommendations are premature. Further high-quality research is needed.
Key Findings
Further high-quality research is needed.
Outcomes Measured
- Requires manual extraction
Population
| Field | Value |
|---|---|
| Population | See abstract |
| Sample Size | See abstract |
| Age Range | See abstract |
| Condition | See abstract |
MeSH Terms
- Humans
- Antioxidants
- Neoplasms
- Dietary Supplements
- Radiotherapy
- Radiation Injuries
- Stomatitis
- Quality of Life
Evidence Classification
- Level: Systematic Review
- Publication Types: Journal Article, Systematic Review
- Vertical: green-tea
Provenance
- PMID: 40691411
- DOI: 10.1007/s10238-025-01804-x
- PMCID: PMC12279893
- Verified: 2026-04-09 via PubMed E-utilities API
Source extracted via PubMed E-utilities API on 2026-04-09